| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -150 @ USD 152.97 | USD -22,946 | The ETF sold 150 shares of DVA on 2025-03-31. The shares were previously bought for an average price of USD 156.098. The DaVita HealthCare Partners Inc shares were sold for -2.0% lower than average price of previous purchases. This resulted in an overall loss of USD 469 The average price that the ETF previously sold DVA share for is USD 154.212 which is higher than the selling price of USD 152.97 on 2025-03-31. |
| CRL - Creightons Plc | SELL | -168 @ USD 150.52 | USD -25,287 | The ETF sold 168 shares of CRL on 2025-03-31. The shares were previously bought for an average price of USD 173.59. The Creightons Plc shares were sold for -13.3% lower than average price of previous purchases. This resulted in an overall loss of USD 3,876 The average price that the ETF previously sold CRL share for is USD 196.036 which is higher than the selling price of USD 150.52 on 2025-03-31. |
| HSIC - Henry Schein Inc | SELL | -402 @ USD 68.49 | USD -27,533 | The ETF sold 402 shares of HSIC on 2025-03-31. The shares were previously bought for an average price of USD 74.0087. The Henry Schein Inc shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,219 The average price that the ETF previously sold HSIC share for is USD 71.5443 which is higher than the selling price of USD 68.49 on 2025-03-31. |
| TECH - Bio-Techne Corp | SELL | -510 @ USD 58.63 | USD -29,901 | The ETF sold 510 shares of TECH on 2025-03-31. The shares were previously bought for an average price of USD 67.6671. The Bio-Techne Corp shares were sold for -13.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,609 The average price that the ETF previously sold TECH share for is USD 72.8765 which is higher than the selling price of USD 58.63 on 2025-03-31. |
| MRNA - Moderna Inc | SELL | -1,068 @ USD 28.35 | USD -30,278 | The ETF sold 1068 shares of MRNA on 2025-03-31. The shares were previously bought for an average price of USD 37.524. The Moderna Inc shares were sold for -24.4% lower than average price of previous purchases. This resulted in an overall loss of USD 9,798 The average price that the ETF previously sold MRNA share for is USD 43.5549 which is higher than the selling price of USD 28.35 on 2025-03-31. |
| INCY - Incyte Corporation | SELL | -522 @ USD 60.55 | USD -31,607 | The ETF sold 522 shares of INCY on 2025-03-31. The shares were previously bought for an average price of USD 70.5537. The Incyte Corporation shares were sold for -14.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,222 The average price that the ETF previously sold INCY share for is USD 74.181 which is higher than the selling price of USD 60.55 on 2025-03-31. |
| SOLV - Solventum Corp. | SELL | -432 @ USD 76.04 | USD -32,849 | The ETF sold 432 shares of SOLV on 2025-03-31. The shares were previously bought for an average price of USD 74.6383. The Solventum Corp. shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of USD 606 The average price that the ETF previously sold SOLV share for is USD 70.2036 so the ETF has sold 432 shares on 2025-03-31 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -3,876 @ USD 8.71 | USD -33,760 | The ETF sold 3876 shares of VTRS on 2025-03-31. The shares were previously bought for an average price of USD 10.7415. The Viatris Inc shares were sold for -18.9% lower than average price of previous purchases. This resulted in an overall loss of USD 7,874 The average price that the ETF previously sold VTRS share for is USD 12.6658 which is higher than the selling price of USD 8.71 on 2025-03-31. |
| UHS - Universal Health Services Inc | SELL | -186 @ USD 187.9 | USD -34,949 | The ETF sold 186 shares of UHS on 2025-03-31. The shares were previously bought for an average price of USD 190.646. The Universal Health Services Inc shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 511 The average price that the ETF previously sold UHS share for is USD 193.829 which is higher than the selling price of USD 187.9 on 2025-03-31. |
| ALGN - Align Technology Inc | SELL | -234 @ USD 158.86 | USD -37,173 | The ETF sold 234 shares of ALGN on 2025-03-31. The shares were previously bought for an average price of USD 192.094. The Align Technology Inc shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 7,777 The average price that the ETF previously sold ALGN share for is USD 221.725 which is higher than the selling price of USD 158.86 on 2025-03-31. |
| RVTY - Revvity Inc. | SELL | -402 @ USD 105.8 | USD -42,532 | The ETF sold 402 shares of RVTY on 2025-03-31. The shares were previously bought for an average price of USD 114.37. The Revvity Inc. shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 3,445 The average price that the ETF previously sold RVTY share for is USD 115.707 which is higher than the selling price of USD 105.8 on 2025-03-31. |
| HOLX - Hologic Inc | SELL | -726 @ USD 61.77 | USD -44,845 | The ETF sold 726 shares of HOLX on 2025-03-31. The shares were previously bought for an average price of USD 68.4165. The Hologic Inc shares were sold for -9.7% lower than average price of previous purchases. This resulted in an overall loss of USD 4,825 The average price that the ETF previously sold HOLX share for is USD 73.568 which is higher than the selling price of USD 61.77 on 2025-03-31. |
| WST - West Pharmaceutical Services Inc | SELL | -234 @ USD 223.88 | USD -52,388 | The ETF sold 234 shares of WST on 2025-03-31. The shares were previously bought for an average price of USD 265.753. The West Pharmaceutical Services Inc shares were sold for -15.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,798 The average price that the ETF previously sold WST share for is USD 315.708 which is higher than the selling price of USD 223.88 on 2025-03-31. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -660 @ USD 84.35 | USD -55,671 | The ETF sold 660 shares of COO on 2025-03-31. The shares were previously bought for an average price of USD 90.5592. The The Cooper Companies, Inc. Common Stock shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,098 The average price that the ETF previously sold COO share for is USD 98.1013 which is higher than the selling price of USD 84.35 on 2025-03-31. |
| BAX - Baxter International Inc | SELL | -1,644 @ USD 34.23 | USD -56,274 | The ETF sold 1644 shares of BAX on 2025-03-31. The shares were previously bought for an average price of USD 33.5469. The Baxter International Inc shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 1,123 The average price that the ETF previously sold BAX share for is USD 32.614 so the ETF has sold 1644 shares on 2025-03-31 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -180 @ USD 329.39 | USD -59,290 | The ETF sold 180 shares of MOH on 2025-03-31. The shares were previously bought for an average price of USD 305.2. The MOH shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of USD 4,354 The average price that the ETF previously sold MOH share for is USD 304.391 so the ETF has sold 180 shares on 2025-03-31 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -180 @ USD 329.39 | USD -59,290 | The ETF sold 180 shares of MOH on 2025-03-31. The shares were previously bought for an average price of USD 305.2. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of USD 4,354 The average price that the ETF previously sold MOH share for is USD 304.391 so the ETF has sold 180 shares on 2025-03-31 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -228 @ USD 262.61 | USD -59,875 | The ETF sold 228 shares of PODD on 2025-03-31. The shares were previously bought for an average price of USD 269.843. The Insulet Corporation shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,649 The average price that the ETF previously sold PODD share for is USD 261.21 so the ETF has sold 228 shares on 2025-03-31 at a higher price than the previous selling average. |
| DGX - Quest Diagnostics Incorporated | SELL | -366 @ USD 169.2 | USD -61,927 | The ETF sold 366 shares of DGX on 2025-03-31. The shares were previously bought for an average price of USD 165.988. The Quest Diagnostics Incorporated shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of USD 1,176 The average price that the ETF previously sold DGX share for is USD 158.231 so the ETF has sold 366 shares on 2025-03-31 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -270 @ USD 232.74 | USD -62,840 | The ETF sold 270 shares of LH on 2025-03-31. The shares were previously bought for an average price of USD 242.796. The Laboratory Corporation of America Holdings shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,715 The average price that the ETF previously sold LH share for is USD 236.486 which is higher than the selling price of USD 232.74 on 2025-03-31. |
| BIIB - Biogen Inc | SELL | -474 @ USD 136.84 | USD -64,862 | The ETF sold 474 shares of BIIB on 2025-03-31. The shares were previously bought for an average price of USD 150.412. The Biogen Inc shares were sold for -9.0% lower than average price of previous purchases. This resulted in an overall loss of USD 6,433 The average price that the ETF previously sold BIIB share for is USD 161.816 which is higher than the selling price of USD 136.84 on 2025-03-31. |
| WAT - Waters Corporation | SELL | -192 @ USD 368.57 | USD -70,765 | The ETF sold 192 shares of WAT on 2025-03-31. The shares were previously bought for an average price of USD 373.796. The Waters Corporation shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,003 The average price that the ETF previously sold WAT share for is USD 375.853 which is higher than the selling price of USD 368.57 on 2025-03-31. |
| WAT - MULETFWATIMETFP | SELL | -192 @ USD 368.57 | USD -70,765 | The ETF sold 192 shares of WAT on 2025-03-31. The shares were previously bought for an average price of USD 373.796. The MULETFWATIMETFP shares were sold for -1.4% lower than average price of previous purchases. This resulted in an overall loss of USD 1,003 The average price that the ETF previously sold WAT share for is USD 375.853 which is higher than the selling price of USD 368.57 on 2025-03-31. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -642 @ USD 113.18 | USD -72,662 | The ETF sold 642 shares of ZBH on 2025-03-31. The shares were previously bought for an average price of USD 107.317. The Zimmer Biomet Holdings Inc shares were sold for 5.5% higher than average price of previous purchases. This sale made a profit of USD 3,764 The average price that the ETF previously sold ZBH share for is USD 107.674 so the ETF has sold 642 shares on 2025-03-31 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -324 @ USD 226.65 | USD -73,435 | The ETF sold 324 shares of STE on 2025-03-31. The shares were previously bought for an average price of USD 221.36. The STERIS plc shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 1,714 The average price that the ETF previously sold STE share for is USD 214.136 so the ETF has sold 324 shares on 2025-03-31 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -66 @ USD 1180.91 | USD -77,940 | The ETF sold 66 shares of MTD on 2025-03-31. The shares were previously bought for an average price of USD 1268.11. The Mettler-Toledo International Inc shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 5,755 The average price that the ETF previously sold MTD share for is USD 1255.98 which is higher than the selling price of USD 1180.91 on 2025-03-31. |
| MTD - AMUNDI EUR GOV 710 | SELL | -66 @ USD 1180.91 | USD -77,940 | The ETF sold 66 shares of MTD on 2025-03-31. The shares were previously bought for an average price of USD 1268.11. The AMUNDI EUR GOV 710 shares were sold for -6.9% lower than average price of previous purchases. This resulted in an overall loss of USD 5,755 The average price that the ETF previously sold MTD share for is USD 1255.98 which is higher than the selling price of USD 1180.91 on 2025-03-31. |
| DXCM - DexCom Inc | SELL | -1,272 @ USD 68.29 | USD -86,865 | The ETF sold 1272 shares of DXCM on 2025-03-31. The shares were previously bought for an average price of USD 79.4126. The DexCom Inc shares were sold for -14.0% lower than average price of previous purchases. This resulted in an overall loss of USD 14,148 The average price that the ETF previously sold DXCM share for is USD 75.9863 which is higher than the selling price of USD 68.29 on 2025-03-31. |
| IQV - IQVIA Holdings Inc | SELL | -546 @ USD 176.3 | USD -96,260 | The ETF sold 546 shares of IQV on 2025-03-31. The shares were previously bought for an average price of USD 199.526. The IQVIA Holdings Inc shares were sold for -11.6% lower than average price of previous purchases. This resulted in an overall loss of USD 12,681 The average price that the ETF previously sold IQV share for is USD 201.921 which is higher than the selling price of USD 176.3 on 2025-03-31. |
| CNC - Concurrent Technologies Plc | SELL | -1,626 @ USD 60.71 | USD -98,714 | The ETF sold 1626 shares of CNC on 2025-03-31. The shares were previously bought for an average price of USD 59.961. The Concurrent Technologies Plc shares were sold for 1.2% higher than average price of previous purchases. This sale made a profit of USD 1,218 The average price that the ETF previously sold CNC share for is USD 59.9598 so the ETF has sold 1626 shares on 2025-03-31 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -390 @ USD 264.6 | USD -103,194 | The ETF sold 390 shares of HUM on 2025-03-31. The shares were previously bought for an average price of USD 272.425. The Hummingbird Resources PLC shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,052 The average price that the ETF previously sold HUM share for is USD 279.443 which is higher than the selling price of USD 264.6 on 2025-03-31. |
| HUM - Humana Inc | SELL | -390 @ USD 264.6 | USD -103,194 | The ETF sold 390 shares of HUM on 2025-03-31. The shares were previously bought for an average price of USD 272.425. The Humana Inc shares were sold for -2.9% lower than average price of previous purchases. This resulted in an overall loss of USD 3,052 The average price that the ETF previously sold HUM share for is USD 279.443 which is higher than the selling price of USD 264.6 on 2025-03-31. |
| RMD - ResMed Inc | SELL | -480 @ USD 223.85 | USD -107,448 | The ETF sold 480 shares of RMD on 2025-03-31. The shares were previously bought for an average price of USD 236.04. The ResMed Inc shares were sold for -5.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,851 The average price that the ETF previously sold RMD share for is USD 241.807 which is higher than the selling price of USD 223.85 on 2025-03-31. |
| A - Agilent Technologies Inc | SELL | -930 @ USD 116.98 | USD -108,791 | The ETF sold 930 shares of A on 2025-03-31. The shares were previously bought for an average price of USD 133.243. The Agilent Technologies Inc shares were sold for -12.2% lower than average price of previous purchases. This resulted in an overall loss of USD 15,125 The average price that the ETF previously sold A share for is USD 135.189 which is higher than the selling price of USD 116.98 on 2025-03-31. |
| CAH - Cardinal Health Inc | SELL | -792 @ USD 137.77 | USD -109,114 | The ETF sold 792 shares of CAH on 2025-03-31. The shares were previously bought for an average price of USD 125.94. The Cardinal Health Inc shares were sold for 9.4% higher than average price of previous purchases. This sale made a profit of USD 9,369 The average price that the ETF previously sold CAH share for is USD 120.49 so the ETF has sold 792 shares on 2025-03-31 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -264 @ USD 419.95 | USD -110,867 | The ETF sold 264 shares of IDXX on 2025-03-31. The shares were previously bought for an average price of USD 441.203. The IDEXX Laboratories Inc shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 5,611 The average price that the ETF previously sold IDXX share for is USD 426.662 which is higher than the selling price of USD 419.95 on 2025-03-31. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,476 @ USD 80.71 | USD -119,128 | The ETF sold 1476 shares of GEHC on 2025-03-31. The shares were previously bought for an average price of USD 87.293. The GE HealthCare Technologies Inc. shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,717 The average price that the ETF previously sold GEHC share for is USD 82.5737 which is higher than the selling price of USD 80.71 on 2025-03-31. |
| EW - Edwards Lifesciences Corp | SELL | -1,926 @ USD 72.48 | USD -139,596 | The ETF sold 1926 shares of EW on 2025-03-31. The shares were previously bought for an average price of USD 71.006. The Edwards Lifesciences Corp shares were sold for 2.1% higher than average price of previous purchases. This sale made a profit of USD 2,839 The average price that the ETF previously sold EW share for is USD 70.1111 so the ETF has sold 1926 shares on 2025-03-31 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -564 @ USD 278.09 | USD -156,843 | The ETF sold 564 shares of COR on 2025-03-31. The shares were previously bought for an average price of USD 247.528. The Cencora Inc. shares were sold for 12.3% higher than average price of previous purchases. This sale made a profit of USD 17,237 The average price that the ETF previously sold COR share for is USD 241.807 so the ETF has sold 564 shares on 2025-03-31 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -582 @ USD 345.55 | USD -201,110 | The ETF sold 582 shares of HCA on 2025-03-31. The shares were previously bought for an average price of USD 335.865. The HCA Holdings Inc shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of USD 5,637 The average price that the ETF previously sold HCA share for is USD 324.775 so the ETF has sold 582 shares on 2025-03-31 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -936 @ USD 229.06 | USD -214,400 | The ETF sold 936 shares of BDX on 2025-03-31. The shares were previously bought for an average price of USD 231.479. The Becton Dickinson and Company shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,264 The average price that the ETF previously sold BDX share for is USD 226.545 so the ETF has sold 936 shares on 2025-03-31 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -342 @ USD 634.23 | USD -216,907 | The ETF sold 342 shares of REGN on 2025-03-31. The shares were previously bought for an average price of USD 728.665. The Regeneron Pharmaceuticals Inc shares were sold for -13.0% lower than average price of previous purchases. This resulted in an overall loss of USD 32,297 The average price that the ETF previously sold REGN share for is USD 768.905 which is higher than the selling price of USD 634.23 on 2025-03-31. |
| ZTS - Zoetis Inc | SELL | -1,458 @ USD 164.65 | USD -240,060 | The ETF sold 1458 shares of ZTS on 2025-03-31. The shares were previously bought for an average price of USD 169.296. The Zoetis Inc shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 6,774 The average price that the ETF previously sold ZTS share for is USD 173.536 which is higher than the selling price of USD 164.65 on 2025-03-31. |
| MCK - McKesson Corporation | SELL | -408 @ USD 672.99 | USD -274,580 | The ETF sold 408 shares of MCK on 2025-03-31. The shares were previously bought for an average price of USD 604.609. The McKesson Corporation shares were sold for 11.3% higher than average price of previous purchases. This sale made a profit of USD 27,899 The average price that the ETF previously sold MCK share for is USD 593.297 so the ETF has sold 408 shares on 2025-03-31 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -4,104 @ USD 67.75 | USD -278,046 | The ETF sold 4104 shares of CVS on 2025-03-31. The shares were previously bought for an average price of USD 61.922. The CVS Health Corp shares were sold for 9.4% higher than average price of previous purchases. This sale made a profit of USD 23,918 The average price that the ETF previously sold CVS share for is USD 54.0605 so the ETF has sold 4104 shares on 2025-03-31 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -894 @ USD 329 | USD -294,126 | The ETF sold 894 shares of CI on 2025-03-31. The shares were previously bought for an average price of USD 312.905. The Cigna Corp shares were sold for 5.1% higher than average price of previous purchases. This sale made a profit of USD 14,389 The average price that the ETF previously sold CI share for is USD 311.691 so the ETF has sold 894 shares on 2025-03-31 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -750 @ USD 434.96 | USD -326,220 | The ETF sold 750 shares of ELV on 2025-03-31. The shares were previously bought for an average price of USD 407.535. The Elevance Health Inc shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of USD 20,569 The average price that the ETF previously sold ELV share for is USD 399.642 so the ETF has sold 750 shares on 2025-03-31 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -750 @ USD 434.96 | USD -326,220 | The ETF sold 750 shares of ELV on 2025-03-31. The shares were previously bought for an average price of USD 407.535. The Elevance Health Inc shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of USD 20,569 The average price that the ETF previously sold ELV share for is USD 399.642 so the ETF has sold 750 shares on 2025-03-31 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -4,170 @ USD 89.86 | USD -374,716 | The ETF sold 4170 shares of MDT on 2025-03-31. The shares were previously bought for an average price of USD 89.2946. The Medtronic PLC shares were sold for 0.6% higher than average price of previous purchases. This sale made a profit of USD 2,358 The average price that the ETF previously sold MDT share for is USD 85.3618 so the ETF has sold 4170 shares on 2025-03-31 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -6,606 @ USD 60.99 | USD -402,900 | The ETF sold 6606 shares of BMY on 2025-03-31. The shares were previously bought for an average price of USD 57.9853. The Bloomsbury Publishing Plc shares were sold for 5.2% higher than average price of previous purchases. This sale made a profit of USD 19,849 The average price that the ETF previously sold BMY share for is USD 56.9682 so the ETF has sold 6606 shares on 2025-03-31 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -834 @ USD 484.82 | USD -404,340 | The ETF sold 834 shares of VRTX on 2025-03-31. The shares were previously bought for an average price of USD 478.699. The Vertex Pharmaceuticals Inc shares were sold for 1.3% higher than average price of previous purchases. This sale made a profit of USD 5,105 The average price that the ETF previously sold VRTX share for is USD 463.479 so the ETF has sold 834 shares on 2025-03-31 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -1,122 @ USD 372.25 | USD -417,665 | The ETF sold 1122 shares of SYK on 2025-03-31. The shares were previously bought for an average price of USD 381.378. The Stryker Corporation shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of USD 10,242 The average price that the ETF previously sold SYK share for is USD 375.934 which is higher than the selling price of USD 372.25 on 2025-03-31. |
| DHR - Danaher Corporation | SELL | -2,088 @ USD 205 | USD -428,040 | The ETF sold 2088 shares of DHR on 2025-03-31. The shares were previously bought for an average price of USD 221.122. The Danaher Corporation shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 33,663 The average price that the ETF previously sold DHR share for is USD 236.511 which is higher than the selling price of USD 205 on 2025-03-31. |
| DHR - Danaher Corporation | SELL | -2,088 @ USD 205 | USD -428,040 | The ETF sold 2088 shares of DHR on 2025-03-31. The shares were previously bought for an average price of USD 221.122. The Danaher Corporation shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 33,663 The average price that the ETF previously sold DHR share for is USD 236.511 which is higher than the selling price of USD 205 on 2025-03-31. |
| GILD - Guild Esports Plc | SELL | -4,062 @ USD 112.05 | USD -455,147 | The ETF sold 4062 shares of GILD on 2025-03-31. The shares were previously bought for an average price of USD 101.898. The Guild Esports Plc shares were sold for 10.0% higher than average price of previous purchases. This sale made a profit of USD 41,237 The average price that the ETF previously sold GILD share for is USD 92.983 so the ETF has sold 4062 shares on 2025-03-31 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -18,456 @ USD 25.34 | USD -467,675 | The ETF sold 18456 shares of PFE on 2025-03-31. The shares were previously bought for an average price of USD 26.27. The Pfizer Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 17,164 The average price that the ETF previously sold PFE share for is USD 26.2833 which is higher than the selling price of USD 25.34 on 2025-03-31. |
| BSX - Boston Scientific Corporation | SELL | -4,794 @ USD 100.88 | USD -483,619 | The ETF sold 4794 shares of BSX on 2025-03-31. The shares were previously bought for an average price of USD 98.0575. The Boston Scientific Corporation shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of USD 13,531 The average price that the ETF previously sold BSX share for is USD 89.4554 so the ETF has sold 4794 shares on 2025-03-31 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -4,794 @ USD 100.88 | USD -483,619 | The ETF sold 4794 shares of BSX on 2025-03-31. The shares were previously bought for an average price of USD 98.0575. The MULSTRXSSXIMETFP shares were sold for 2.9% higher than average price of previous purchases. This sale made a profit of USD 13,531 The average price that the ETF previously sold BSX share for is USD 89.4554 so the ETF has sold 4794 shares on 2025-03-31 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,752 @ USD 311.55 | USD -545,836 | The ETF sold 1752 shares of AMGN on 2025-03-31. The shares were previously bought for an average price of USD 305.537. The Amgen Inc shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 10,535 The average price that the ETF previously sold AMGN share for is USD 289.298 so the ETF has sold 1752 shares on 2025-03-31 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -1,164 @ USD 495.27 | USD -576,494 | The ETF sold 1164 shares of ISRG on 2025-03-31. The shares were previously bought for an average price of USD 549.278. The Intuitive Surgical Inc shares were sold for -9.8% lower than average price of previous purchases. This resulted in an overall loss of USD 62,865 The average price that the ETF previously sold ISRG share for is USD 534.064 which is higher than the selling price of USD 495.27 on 2025-03-31. |
| TMO - Time Out Group plc | SELL | -1,248 @ USD 497.6 | USD -621,005 | The ETF sold 1248 shares of TMO on 2025-03-31. The shares were previously bought for an average price of USD 537.238. The Time Out Group plc shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 49,468 The average price that the ETF previously sold TMO share for is USD 532.182 which is higher than the selling price of USD 497.6 on 2025-03-31. |
| MRK - Marks Electrical Group PLC | SELL | -8,244 @ USD 89.76 | USD -739,981 | The ETF sold 8244 shares of MRK on 2025-03-31. The shares were previously bought for an average price of USD 93.8288. The Marks Electrical Group PLC shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 33,543 The average price that the ETF previously sold MRK share for is USD 100.836 which is higher than the selling price of USD 89.76 on 2025-03-31. |
| MRK - Merck & Company Inc | SELL | -8,244 @ USD 89.76 | USD -739,981 | The ETF sold 8244 shares of MRK on 2025-03-31. The shares were previously bought for an average price of USD 93.8288. The Merck & Company Inc shares were sold for -4.3% lower than average price of previous purchases. This resulted in an overall loss of USD 33,543 The average price that the ETF previously sold MRK share for is USD 100.836 which is higher than the selling price of USD 89.76 on 2025-03-31. |
| ABT - Abbott Laboratories | SELL | -5,652 @ USD 132.65 | USD -749,738 | The ETF sold 5652 shares of ABT on 2025-03-31. The shares were previously bought for an average price of USD 125.995. The Abbott Laboratories shares were sold for 5.3% higher than average price of previous purchases. This sale made a profit of USD 37,614 The average price that the ETF previously sold ABT share for is USD 116.309 so the ETF has sold 5652 shares on 2025-03-31 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -5,754 @ USD 209.52 | USD -1,205,578 | The ETF sold 5754 shares of ABBV on 2025-03-31. The shares were previously bought for an average price of USD 192.826. The AbbVie Inc shares were sold for 8.7% higher than average price of previous purchases. This sale made a profit of USD 96,057 The average price that the ETF previously sold ABBV share for is USD 184.564 so the ETF has sold 5754 shares on 2025-03-31 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -7,848 @ USD 165.84 | USD -1,301,512 | The ETF sold 7848 shares of JNJ on 2025-03-31. The shares were previously bought for an average price of USD 158.959. The Johnson & Johnson shares were sold for 4.3% higher than average price of previous purchases. This sale made a profit of USD 54,002 The average price that the ETF previously sold JNJ share for is USD 152.258 so the ETF has sold 7848 shares on 2025-03-31 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -3,000 @ USD 523.75 | USD -1,571,250 | The ETF sold 3000 shares of UNH on 2025-03-31. The shares were previously bought for an average price of USD 537.78. The UnitedHealth Group Incorporated shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 42,090 The average price that the ETF previously sold UNH share for is USD 567.818 which is higher than the selling price of USD 523.75 on 2025-03-31. |
| LLY - Eli Lilly and Company | SELL | -2,568 @ USD 825.91 | USD -2,120,937 | The ETF sold 2568 shares of LLY on 2025-03-31. The shares were previously bought for an average price of USD 846.704. The Eli Lilly and Company shares were sold for -2.5% lower than average price of previous purchases. This resulted in an overall loss of USD 53,399 The average price that the ETF previously sold LLY share for is USD 798.337 so the ETF has sold 2568 shares on 2025-03-31 at a higher price than the previous selling average. |